Edition:
United Kingdom

CRISPR Therapeutics AG (CRSP.OQ)

CRSP.OQ on NASDAQ Stock Exchange Global Market

48.92USD
20 Aug 2018
Change (% chg)

-- (--)
Prev Close
$48.92
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
352,575
52-wk High
$73.90
52-wk Low
$16.17

Select another date:

Mon, Jul 16 2018

CRISPR gene editing can cause risky collateral DNA damage: study

LONDON Scientists studying the effects of the potentially game-changing gene editing tool CRISPR/Cas9 have found it can cause unexpected genetic damage which could lead to dangerous changes in some cells.

UPDATE 2-CRISPR gene editing can cause risky collateral DNA damage - study

LONDON, July 16 Scientists studying the effects of the potentially game-changing gene editing tool CRISPR/Cas9 have found it can cause unexpected genetic damage which could lead to dangerous changes in some cells.

BRIEF-Crispr Therapeutics Reports Q1 Loss Per Share $0.62

* CRISPR THERAPEUTICS PROVIDES BUSINESS UPDATE AND REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS

BRIEF-Crispr Therapeutics Qtrly ‍​collaboration Revenue $32.3 Mln

* CRISPR THERAPEUTICS PROVIDES BUSINESS UPDATE AND REPORTS FOURTH QUARTER AND FULL YEAR 2017 FINANCIAL RESULTS

Select another date: